Thrombocytopenic Thrombosis after Janssen Vaccine | Public Health and CDC/FDA Updates | April 19, 2021
Date of Presentation: April 19, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #j&j #Janssen #johnson & johnson #public health updates #thrombocytopenic thrombosis
In this series of presentations, ECHO faculty members, Dr. Thomas Weiser, Medical Epidemiologist and Ex-Officio Representative from IHS on the ACIP, and Dr. Harry Brown, Medical Epidemiologist with USET, review COVID-19 vaccines, provide a summary of the April 14th ACIP Emergency meeting, and discuss thrombocytopenic thrombosis after the Janssen vaccine. Then, Dr. Eileen M. Dunne, PhD, ECHO faculty member and Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health, provides a public health practice update and a number of valuable COVID-19 related resources produced by HHS, CDC and FDA.
Recording:
Presented by:
Dr. Harry J Brown, Dr. Tom Weiser, Dr. Eileen M Dunne
Harry J Brown, MD, is a retired Captain in the U.S. Public Health Service. He spent over 26 years in uniform, and all of his career was spent in the Indian Health Service. He attended the University of Texas Medical Branch in Galveston, Texas, and completed a residency in family medicine at the Medical University of South Carolina in Charleston, SC. Harry is board certified in family medicine. He served as the Chief Medical Officer for the Nashville Area from 2007 – 2014, and as Acting Chief Medical Officer for the Billings Area for 2015. He currently works as a hospitalist for the Eastern Band of Cherokee Indians in Cherokee, NC, and as a medical epidemiologist for the United South and Eastern Tribes in Nashville, TN as part of their Tribal Epidemiology Center.
Thomas Weiser, MD, is the Medical Epidemiologist for the Portland Area Indian Health Service assigned to the Northwest Portland Area Indian Health Board and NW Tribal Epidemiology Center. He has been with PHS since 1998, initially serving as an IHS Medical Officer in Whiteriver, Arizona from 1998-2005. He completed the CDC Epidemic Intelligence Service from 2005-2007. In addition to supporting general public health and epidemiologic research at the NW Tribal Epidemiology Center, Tom is also the Co-Chair of the Portland Area IHS Institutional Review Board. Nationally, he has served on the IHS Heroin, Opioids and Pain Efforts (HOPE) Committee as the Chair of the Metrics Sub-committee and since 2018 has served as the IHS ex-officio representative to the CDC Advisory Committee on Immunization Practices (ACIP).
Eileen M. Dunne, PhD, is an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention assigned to the Idaho Department of Health & Welfare. Eileen has a Ph.D. in microbiology from Boston University and spent nine years at the Murdoch Children’s Research Institute in Melbourne, Australia conducting clinical research on pediatric infections and pneumococcal vaccines. Her primary interests include infectious diseases, immunization, and public health.
Resources Provided:
- Thrombocytopenic Thrombosis after Janssen Vaccine (Presentation Slides)
- Public Health and Practice Updates (Presentation Slides)
- Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine (CDC)
- COVID-19 Vaccinations in the United States (CDC)
- Vaccine Adverse Event Reporting System (HHS)
- Emergency Use Authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody Test System (FDA)
- FDA Recommends Transition from Use of Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities (FDA)
- Strategies for Optimizing the Supply of N95 Respirators (CDC)
- FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab (FDA)
- Health Center COVID-19 Vaccine Program Participants (HRSA)
- Vaccine Hesitancy for COVID-19: State, County and Local Estimates (ASPE)
- Covid-19: the eight vaccine technologies being tested (International Veterinary Vaccinology Network)
- Thrombocytopenia (low platelet count) (Mayo Clinic)
- AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets (EMA)
- JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021 (GOV.UK)
- Use of Stay-at-Home Orders and Mask Mandates to Control COVID-19 Transmission — Blackfeet Tribal Reservation, Montana, June–December 2020 (MMWR)
- Notes from the Field: COVID-19 Case Investigation and Contact Tracing Program — Spirit Lake Tribe, North Dakota, September–November 2020 (MMWR)
- Emergency Department Visits for COVID-19 by Race and Ethnicity — 13 States, October–December 2020 (MMWR)
- Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region — United States, March–December 2020 (MMWR)
Date added: April 19, 2021